Pampaloni MH1, Nardo L2.
PET Clin. 2014 Jul;9(3):345-9. doi: 10.1016/j.cpet.2014.03.010.The recent development and introduction of new hybrid imaging devices combining positron emission tomography (PET) technology with magnetic resonance imaging (MRI) opens up new perspectives in clinical molecular imaging. Combining MRI and fluorine-18 choline PET would theoretically produce valuable clinical data in a single imaging session, which can be used for staging, prognosis, and assessment of treatment response. Read More